creactiv
protein
crp
acutephas
reactant
found
blood
respons
acut
chronic
inflammatori
condit
broad
clinic
applic
screen
infecti
immunemedi
diseas
crp
import
innat
immun
properti
releas
liver
trigger
proinflammatori
cytokin
tnfa
crp
assay
increas
sensit
highsensit
creactiv
protein
hscrp
demonstr
lowgrad
inflamm
patient
disord
cardiovascular
diseas
obes
diabet
mellitu
increas
hscrp
level
also
demonstr
shortli
viral
respiratori
tract
infect
patient
symptomat
airway
diseas
asthma
chronic
obstruct
pulmonari
diseas
addit
impair
lung
function
asthmat
children
adult
associ
presenc
system
lowgrad
inflamm
hypothes
impair
lung
function
would
associ
system
inflammatori
process
even
develop
respiratori
symptom
therefor
measur
plasma
hscrp
tnfa
formerli
level
earli
age
month
relat
neonat
lung
function
assess
age
week
copenhagen
prospect
studi
asthma
childhood
copsac
birth
cohort
studi
particip
neonat
born
mother
histori
asthma
enrol
week
age
copsac
prospect
birth
cohort
studi
exclus
criteria
respiratori
symptom
respiratori
support
inclus
gestat
age
less
week
congenit
abnorm
system
ill
sever
neonat
sepsi
children
attend
copsac
research
clinic
age
week
assess
neonat
lung
function
subsequ
interv
previous
detail
ethic
studi
conduct
accord
guid
principl
declar
helsinki
approv
local
ethic
committe
kf
danish
data
protect
agenc
parent
provid
oral
written
inform
consent
enrol
level
priori
select
biomark
determin
use
highsensit
elisa
base
electrochemiluminesc
set
tnfa
singl
assay
hscrp
sampl
read
duplic
use
sector
imag
meso
scale
discoveri
gaithersburg
md
limit
detect
mean
signal
blank
pgml
hscrp
pgml
pgml
pgml
pgml
tnfa
neonat
spirometr
result
measur
age
week
appli
raisedvolum
rapid
thoracoabdomin
squeez
jacket
compress
techniqu
repeat
ventil
predefin
mouth
pressur
ensur
expans
lung
volum
instant
inflat
jacket
caus
full
exhal
flow
measur
use
pneumotachograph
aircushion
facemask
softwar
identifi
forc
vital
capac
fvc
first
plateau
volumetim
curv
measur
fvc
appear
second
forc
expiratori
volum
second
fev
less
equal
fvc
accept
three
accept
curv
obtain
measur
curv
contain
median
valu
fev
use
analysi
fev
forc
expiratori
flow
forc
vital
capac
fef
neonat
bronchial
respons
initi
salin
inhal
methacholin
administ
quadrupl
dose
step
dosimet
attach
nebul
spira
tsm
respiratori
care
center
ameenlinna
finland
bronchial
respons
determin
mean
continu
assess
transcutan
oxygen
satur
radiomet
copenhagen
denmark
provoc
dose
methacholin
caus
decreas
transcutan
oxygen
satur
estim
doserespons
curv
fit
logist
function
troublesom
lung
symptom
trol
defin
signific
cough
wheez
dyspnea
sever
affect
wellb
child
record
parent
daili
diari
chart
dichotom
score
yesno
birth
acut
episod
trol
consecut
day
trol
children
seen
copsac
clinic
clinic
examin
includ
rhinopharyng
aspir
viral
detect
picornavirus
respiratori
syncyti
viru
coronavirus
parainfluenza
virus
influenza
virus
human
metapneumovirus
adenovirus
bocaviru
biomark
null
valu
set
half
lowest
detect
valu
specif
biomark
valu
logtransform
mean
duplic
measur
use
associ
analys
z
score
calcul
fev
fef
provoc
dose
methacholin
caus
decreas
transcutan
oxygen
satur
logtransform
obtain
normal
associ
neonat
lung
function
indic
inflammatori
biomark
test
use
convent
statist
gener
linear
model
use
unsupervis
pattern
recognit
princip
compon
analysi
pca
pca
analys
extract
underli
orthogon
compon
describ
systemat
part
variat
across
biomark
use
logtransform
z
score
mediat
level
result
present
raw
estim
ci
estim
obtain
partial
regress
analys
adjust
covari
associ
level
hscrp
use
cutoff
p
valu
less
birth
bmi
matern
smoke
third
trimest
retain
multivari
model
independ
associ
hscrp
import
determin
neonat
lung
function
interact
bacteri
airway
colon
trol
acut
episod
trol
viru
detect
test
ad
crossproduct
model
p
valu
less
consid
signific
analys
done
sa
softwar
version
sa
institut
cari
nc
measur
tnfa
level
perform
plasma
sampl
collect
age
month
measur
hscrp
level
perform
plasma
sampl
collect
age
month
one
sampl
lost
technic
reason
perform
assay
result
children
origin
cohort
children
avail
measur
biomark
found
signific
differ
baselin
characterist
children
without
avail
biomark
assess
see
tabl
articl
onlin
repositori
www
jacionlineorg
median
level
follow
hscrp
mgl
interquartil
rang
iqr
mgl
ngl
iqr
ngl
ngl
iqr
ngl
tnfa
ngl
iqr
ngl
ngl
iqr
ng
l
tnfa
level
strongli
posit
correl
hscrp
level
p
wherea
level
correl
hscrp
level
p
measur
valu
hscrp
tnfa
within
expect
rang
null
valu
wherea
level
much
lower
expect
null
valu
children
fact
shown
significantli
degrad
time
even
includ
analys
children
older
children
home
birth
significantli
higher
hscrp
level
age
month
compar
children
without
older
children
home
median
hs
detect
associ
hscrp
level
patern
histori
asthma
eczema
allergi
child
sex
birth
bmi
household
incom
matern
smoke
third
trimest
pregnanc
birth
mean
cesarean
section
breastfeed
day
care
attend
pet
home
tabl
neonat
lung
function
system
lowgrad
inflamm
hscrp
convent
statist
approach
show
strong
linear
invers
associ
fev
valu
age
week
hscrp
level
age
month
bcoeffici
ci
p
suggest
increas
grade
inflamm
diminish
neonat
lung
function
fig
associ
unchang
adjust
older
children
home
bacteri
airway
colon
age
week
infect
day
trol
well
acut
virusrel
episod
trol
time
biomark
assess
birth
bmi
matern
smoke
third
trimest
bcoeffici
ci
p
furthermor
found
interact
bacteri
airway
colon
p
trol
p
acut
episod
trol
viru
detect
p
fef
valu
also
seem
invers
associ
hscrp
level
signific
bcoeffici
ci
p
increas
fev
valu
also
significantli
associ
decreas
level
bcoeffici
ci
p
fig
confound
adjust
substanti
chang
associ
bcoeffici
ci
p
detect
signific
associ
fef
valu
level
tnfa
fev
fef
measur
associ
tnfa
level
although
bcoeffici
suggest
invers
associ
lung
function
indic
tnfa
level
tabl
ii
pca
unsupervis
pca
show
hscrp
tnfa
level
posit
correl
first
princip
compon
explain
total
variat
data
pca
approach
illustr
biplot
fig
show
score
load
biomark
univoc
pattern
focus
analys
confirm
find
convent
statist
found
fev
valu
invers
associ
valu
p
remain
signific
confound
adjust
p
interact
bacteri
airway
colon
trol
acut
episod
trol
viru
detect
interact
p
bcoeffici
also
suggest
invers
associ
fef
valu
model
signific
tabl
ii
bronchial
respons
methacholin
neonat
life
associ
biomark
lowgrad
inflamm
age
month
tabl
ii
infant
reduc
pulmonari
capac
neonat
character
system
lowgrad
inflamm
upregul
blood
inflammatori
respons
includ
increas
hscrp
level
associ
suggest
reduc
neonat
lung
function
part
condit
ongo
asymptomat
airway
inflamm
measur
system
compon
begin
life
major
strength
studi
uniqu
assess
neonat
lung
function
stateoftheart
raisedvolum
rapid
thoracoabdomin
compress
techniqu
perform
strictli
adher
recogn
guidelin
full
motherchild
birth
cohort
neonat
spirometr
measur
obtain
cohort
asymptomat
children
respiratori
symptom
thu
unbias
previou
concurr
airway
symptom
anoth
signific
strength
studi
avail
rang
environment
exposur
assess
includ
bacteri
airway
colon
presenc
viru
enabl
robust
confound
adjust
factor
possibl
influenc
neonat
lung
function
lowgrad
inflamm
howev
limit
assess
presenc
bacteria
virus
lung
function
inflammatori
biomark
test
strong
linear
correl
tnfa
level
hscrp
level
tnfa
main
trigger
crp
releas
liver
expect
correl
serv
biolog
valid
data
lack
correl
hscrp
level
surpris
primarili
neutrophil
chemotact
function
innat
immun
system
directli
induc
crp
releas
find
significantli
increas
hscrp
level
children
experienc
infecti
episod
within
day
biomark
assess
valid
data
crp
reliabl
biomark
airway
inflamm
even
adjust
confound
associ
neonat
lung
function
hscrp
level
remain
larg
unchang
effect
estim
standard
statist
approach
unsupervis
datadriven
pca
approach
show
similar
associ
strengthen
confid
find
still
detect
associ
neonat
bronchial
hyperrespons
lowgrad
inflamm
would
expect
given
previou
find
associ
methacholin
challeng
result
subsequ
asthma
develop
limit
studi
unabl
detect
biolog
meaning
signal
presum
caus
part
plasma
storag
time
year
analysi
sampl
thaw
frozen
sever
occas
particularli
sensit
freezethaw
cycl
degrad
greater
time
even
sampl
store
well
known
circul
level
approxim
time
less
tnfa
level
healthi
adult
case
median
level
time
less
median
tnfa
level
vs
ngl
unabl
detect
associ
hscrp
level
anoth
limit
studi
atrisk
natur
cohort
children
born
mother
histori
asthma
demonstr
recent
offspr
mother
histori
asthma
allergi
eczema
unselect
motherchild
cohort
topic
downregul
immun
signatur
airway
mucosa
compar
children
mother
without
disord
yet
even
though
atrisk
natur
cohort
might
affect
absolut
biomark
level
influenc
abil
explor
associ
neonat
spirometri
marker
system
lowgrad
inflamm
within
cohort
anoth
limit
studi
biomark
assess
month
neonat
lung
function
test
week
howev
adjust
lung
symptom
period
base
daili
diari
card
fill
parent
show
impair
lung
function
neonat
associ
system
inflammatori
process
even
develop
respiratori
symptom
suggest
link
reduc
neonat
lung
function
disord
character
system
inflammatori
compon
number
recent
larger
crosssect
analys
adult
adolesc
shown
increas
hscrp
level
associ
respiratori
impair
populationbas
set
asthmat
nonasthmat
strata
hscrp
level
also
report
relat
pulmonari
function
outcom
studi
children
establish
asthma
studi
asthmat
children
age
year
without
acut
exacerb
studi
schoolag
children
treat
inhal
corticosteroid
well
steroidna
children
show
reciproc
relationship
fev
valu
hscrp
level
contrast
anoth
studi
schoolag
children
control
uncontrol
asthma
detect
associ
hscrp
level
fev
valu
found
hscrp
level
greater
patient
uncontrol
versu
control
asthma
might
reflect
degre
airway
inflamm
studi
might
underpow
hamper
wide
age
rang
lack
control
group
importantli
differ
research
question
whether
establish
asthma
associ
detect
system
inflamm
unlik
aim
studi
whether
system
inflamm
earli
life
associ
neonat
lung
function
symptom
debut
possibl
explan
identifi
associ
reduc
neonat
lung
function
increas
hscrp
level
diminish
forc
volum
caus
airway
inflamm
vitro
murin
human
lung
cell
studi
establish
possibl
role
proinflammatori
cytokin
stimul
crp
releas
tnfa
pathophysiolog
obstruct
airway
inflamm
persist
increas
crp
level
might
induc
increas
vulner
chang
earlylif
environ
action
gener
scaveng
protein
import
innat
immun
function
recognit
elimin
bacteria
damag
human
cell
opson
phagocytosi
cellmedi
cytotox
therefor
reduc
neonat
lung
function
might
reflect
subclin
bacteri
airway
colon
airway
inflamm
predat
detect
clinic
symptom
system
lowgrad
inflamm
diseas
trajectori
well
known
patient
cystic
fibrosi
exampl
reduc
lung
function
shown
preced
clinic
diseas
penetr
correl
pseudomona
aeruginosa
airway
colon
exacerb
altern
reduc
neonat
lung
function
lead
system
inflamm
rather
independ
characterist
neonat
sustain
lowgrad
inflamm
earli
life
ineffici
immun
regul
might
driven
newborn
genotyp
interact
intrauterin
earlylif
environ
therebi
affect
plastic
develop
immun
system
support
latter
theori
higher
baselin
crp
level
demonstr
western
popul
obstruct
airway
disord
preval
compar
rural
societi
assess
lung
function
asymptomat
neonat
inflammatori
biomark
month
specul
whether
concur
onset
underli
disord
whether
possibl
reflect
disord
begin
even
earlier
life
perhap
pregnanc
children
danish
copsac
atrisk
cohort
exhibit
associ
reduc
neonat
lung
function
upregul
system
inflammatori
biomark
symptom
onset
suggest
reduc
lung
function
reflect
ongo
inflammatori
disord
measur
system
compon
earli
life
